Global Endometrial Ablation Devices Market - 2023-2030

Global Endometrial Ablation Devices Market - 2023-2030

The global endometrial ablation device market reached US$ 3.5 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 5.4 billion by 2030. The global endometrial ablation devices market is expected to exhibit a CAGR of 5.6% during the forecast period (2023-2030).

Endometrial ablation devices are significant because they can effectively treat women who have excessive or extended menstrual bleeding, generally known as menorrhagia. Menorrhagia can have a negative influence on a woman's quality of life by producing physical discomfort, mental anguish, and interruption of everyday activities.

Endometrial ablation devices provide a non-surgical option to hysterectomy for women who want to keep their uterus or avoid the hazards of major surgery. It enables patients to treat their problems without having to undergo more intrusive surgery.

Market Dynamics
Rising Prevalence of Endometrial Cancer
The rising prevalence of endometrial cancer is one of the significant key drivers that help the market to grow further during the forecast period. For instance, according to the American Community Survey 2022 updated factsheet, there were over 600,000 endometrial cancer survivors in the United States. According to the same source, around 65,950 new cases of uterine body cancer (uterine body or corpus) are projected to be detected in 2022. As a result, the rising incidence of endometrial cancer is predicted to drive up demand for endometrial ablation devices.

Rise in the Prevalence of Gynaecological Disorders
The rise in the prevalence of gynaecological disorders such as cervical cancer, menorrhagia, abnormal vaginal bleeding, and POCD (polycystic ovarian disease) in women is a major factor driving market growth. Cervical cancer is the fourth most common cancer in women worldwide, according to World Health Organization updates in February 2022, with 604 000 new cases and 342 000 deaths by 2020. Low- and middle-income countries accounted for nearly 90% of new cases and deaths globally by 2020. As a result, the increasing prevalence of gynaecological diseases is expected to drive market growth during the forecast period.

Risks Associated With Endometrial Ablation
While uncommon, the following risks may occur during or shortly after the surgery. Deep uterine damage, such as perforation (tear) or burn beyond the uterine muscle layer, injury to the abdominal organs, such as bowel or bladder perforation (tears) or burns infection, burn harm to the vagina, vulva, and skin haemorrhage (blood loss), embolism of air or gas (air bubble in the blood vessels) can occur.

COVID-19 Impact Analysis
During the COVID-19 epidemic, all outpatient treatments were postponed or limited to minimise the danger of viral transmission, as most chronic therapies were deemed voluntary. According to an article published in the Springer Journal in September 2022, during the COVID-19 pandemic, the number of treatments for endometriosis patients was limited, particularly during the first lockdown.

There was a 37% decrease in the endometriosis outpatient department and a 90% decrease in surgical endometriosis. Thus, the drop in endometrial consultations and surgical operations during COVID-19 had a substantial influence on market growth during the pandemic's early phases.

Russia-Ukraine War Impact Analysis
The Russia-Ukraine conflict is estimated to have a moderate impact on the global endometrial ablation devices market, owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of endometrial ablation devices is expected to have little influence over the global endometrial ablation devices market growth over the forecast period.

Segment Analysis
The global endometrial ablation devices market is segmented based on device type, end user and region.

Hysteroscopy Devices from Device Type Segment Accounts for 23.6% of Market Share

The hysteroscopy devices from the device type segment with around 23.6%. The use of a hysteroscopy instrument offers a real-time picture of the uterine cavity, allowing the clinician to correctly plan and direct the endometrial ablation operation. The hysteroscope aids in visualising the position and extent of the endometrial tissue to be treated, allowing for accurate targeting and total coverage during the ablation procedure. Hysteroscopy instruments allow for continuous monitoring of the treatment progress during the endometrial ablation operation.

For instance, in November 2022, in India, Medtronic introduced a novel instrument for diagnostic and surgical hysteroscopy. India Medtronic, a fully owned subsidiary of Medtronic plc, announced the debut of the TruClear system, a mechanical hysteroscopic tissue removal device used for the safe and effective treatment of intrauterine abnormalities (IUA). Fibroids, polyps, retained products of conception, adhesions, malignancies, or hyperplasia are all examples of IUA.

Geographical Analysis
North America Accounted for Approximately 38.2% of the Market Share
North America is estimated to hold about 38.2% of the total market share throughout the forecast period due to the rising prevalence of gynaecological disorders such as PCOS, abnormal uterine bleeding (AUB), menorrhagia, and escalating cases of cancer such as uterine cancer among women is driving the North American endometrial ablation devices market, which is expected to grow positively.

Competitive Landscape
The major global players in the endometrial ablation devices market include Medtronic, Boston Scientific Corporation, Cooper Surgical, Minerva Surgical, Ethicon, KARL STORZ GmbH & Co. KG, Richard Wolf GmbH, AngioDynamics Inc., Smith & Nephew PLC, Olympus Corporation and others.

Why Purchase the Report?
• To visualize the global endometrial ablation devices market segmentation based on device type, end user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the endometrial ablation devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global endometrial ablation devices market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies